EMEA advice on rosiglitazone

The prescribing information for the type-2 diabetes drug rosiglitazone should be updated to include safety warnings, the European Medicines Agency (EMEA) has announced.

The benefits of using rosiglitazone were found to outweigh the risks, according to the EMEA.

However, it recommends that the prescribing information should be updated to include a warning that, in patients with ischaemic heart disease, rosiglitazone should only be used after careful evaluation of risk.

Additionally, the combination of rosiglitazone and insulin should only be used in exceptional cases and under close supervision.

The changes will be introduced in forthcoming regulatory procedures for rosiglitazone-containing medicines. But no changes will be made to the prescribing information for medicines containing pioglitazone.

Comment below and tell us what you think 

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Face-to-face GP appointments on demand 'unachievable', warns RCGP chair

Face-to-face GP appointments on demand 'unachievable', warns RCGP chair

Calls for general practice to offer face-to-face appointments to all patients who...

Cornwall PCN wheels out electric car fleet to reduce carbon footprint

Cornwall PCN wheels out electric car fleet to reduce carbon footprint

Staff at a primary care network (PCN) in Cornwall have committed to reducing their...

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

Repeat prescribing and SMR overhaul as review finds one in 10 scrips unnecessary

Repeat prescribing and SMR overhaul as review finds one in 10 scrips unnecessary

Repeat prescribing and use of structured medication reviews in general practice are...

BMA demands emergency meeting with government over GP abuse

BMA demands emergency meeting with government over GP abuse

BMA leaders have requested an emergency summit with the government to discuss ‘unacceptable...

Millions of pounds lost to general practice as flagship recruitment scheme falls short

Millions of pounds lost to general practice as flagship recruitment scheme falls short

Tens of millions of pounds in funding from a flagship recruitment scheme set up to...